Sensei Biotherapeutics GAAP EPS of -$16.72

* Sensei Biotherapeutics press release [https://seekingalpha.com/pr/20454976-sensei-biotherapeutics-reports-full-year-2025-financial-results-and-provides-corporate-update] (SNSE [https://seekingalpha.com/symbol/SNSE]): FY GAAP EPS of -$16.72.
* Cash, cash equivalents and marketable securities were $21.2 million as of December 31, 2025 as compared to $41.3 million as of December 31, 2024.

MORE ON SENSEI BIOTHERAPEUTICS

* Sensei Biotherapeutics, Inc. (SNSE) Faeth Therapeutics, Inc. - M&A Call - Slideshow [https://seekingalpha.com/article/4873111-sensei-biotherapeutics-inc-snse-faeth-therapeutics-inc-m-and-a-call-slideshow]
* Nano-cap biotech Sensei surges on $200M private placement, acquisition [https://seekingalpha.com/news/4553347-sensei-surges-private-placement-acquisition]
* Seeking Alpha’s Quant Rating on Sensei Biotherapeutics [https://seekingalpha.com/symbol/SNSE/ratings/quant-ratings]
* Historical earnings data for Sensei Biotherapeutics [https://seekingalpha.com/symbol/SNSE/earnings]
* Financial information for Sensei Biotherapeutics [https://seekingalpha.com/symbol/SNSE/income-statement]